Island Thoracodorsal Artery Perforator-Based v-Y Advancement Flap After Radical Excision of Axillary Hidradenitis.

Island Thoracodorsal Artery Perforator-Based V-Y Advancement Flap After Radical Excision of Axillary Hidradenitis.

Filed under: Rehab Centers

Ann Plast Surg. 2012 Nov 26;
Hallock GG

ABSTRACT: Chronic axillary hidradenitis invariably ultimately requires surgical intervention to ameliorate this often painful, unrelenting, recurrent disease that can be disabling. The treatment of choice requires radical excision of at least all hair-bearing skin and its associated apocrine sweat glands. The ensuing large defect often is amenable to closure using a local flap instead of a skin graft to better expedite healing, to allow more rapid rehabilitation, and to minimize the risk of later scar contracture. The island thoracodorsal artery perforator V-Y advancement flap is another alternative that allows unrestricted insetting with primary donor-site closure, as presented here with 2 clinical examples.
HubMed – rehab

Systemic Inflammatory Pattern of Community-Acquired Pneumonia (CAP) Patients With and Without Chronic Obstructive Pulmonary Disease (COPD).

Filed under: Rehab Centers

Chest. 2012 Sep 24;
Crisafulli E, Menéndez R, Huerta A, Martinez R, Montull B, Clini E, Torres A

ABSTRACT BACKGROUND Several clinical studies have evaluated the role of chronic obstructive pulmonary disease (COPD) in community-acquired pneumonia (CAP) patients. We investigated the systemic inflammatory response of CAP patients with (CAP+COPD) and patients without associated COPD (CAP only). METHODS Clinical, microbiological and immunological data were collected from 367 prospective patients on admission to hospital during a 3-year period. Comparative analyses were performed between CAP+COPD (n=117) and CAP only patients (n=250) and between patients with and without domiciliary use of inhaled (ICS) and oral corticosteroids. RESULTS Detailed characteristics of clinical severity and prognosis (mortality on hospitalization, at 30 days and at 90 days) were similar between CAP+COPD and CAP only patients. The re-admission rate and the frequency of a previous pneumonia were higher in the group of CAP+COPD patients.On day 1 (admission to hospital) CAP+COPD patients had significantly lower serum levels of tumour necrosis factor (TNF) ?, interleukin (IL) 1 and IL-6 compared with CAP only patients; the remaining inflammatory biomarkers (C-reactive protein, procalcitonin, IL-8 and IL-10) were similar at days 1 and 3. The exclusion of patients with domiciliary use of ICS and oral corticosteroids confirms lower levels of TNF-? on day 1 in CAP+COPD patients. Finally, lower levels of IL-6 were found only among those COPD patients who were currently using ICS. CONCLUSION Our prospective study demonstrates a different, disease-specific early inflammatory pattern between CAP patients with and without associated COPD; these finding are not completely corticosteroid-mediated.1Department of Pulmonary Rehabilitation, Ospedale Villa Pineta – University of Modena and Reggio Emilia, Modena, Italy. [email protected], [email protected] de Neumología, Hospital Universitario y politecnico La Fe, CIBERES, Valencia, Spain, [email protected], [email protected], [email protected] Department, Clinic Institute of Thorax (ICT), Hospital Clinic of Barcelona – Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) – University of Barcelona (UB) – Supported by: 2009 SGR 911, Ciber de Enfermedades Respiratorias (Ciberes CB06/06/0028), Pneumonia Corporate Research Program (CRP). The Ciberes is an initiative of the ISCIII. SGR: Support to research groups of Catalunya – Barcelona, Spain. [email protected], [email protected]: Prof. Antoni Torres – Pneumology Department, Clinic Institute of Thorax (ICT), Hospital Clinic, Villarroel 170. 08036 Barcelona, Spain. E-mail: [email protected]/Support: This manuscript was supported by a grant from Marato TV3 – Spain.
HubMed – rehab

Mustard Gas Keratitis: A Common Misnomer.

Filed under: Rehab Centers

Cornea. 2012 Nov 26;
Ghabili K, Shoja MM, Golzari SE, Niyousha MR

HubMed – rehab

More Rehab Centers Information…